Sponsor:
University of Arkansas
Code:
NCT02997293
Conditions
ColoRectal Cancer and Inflammatory Bowel Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Enhanced Recovery protocol
Brief summary:
Conditions
ColoRectal Cancer and Inflammatory Bowel Disease
Study ID
NCT02997293
Start date
Mar 1, 2017
Status verified date
Aug, 2026
Completion date
Jul 1, 2028
Anticipated
Primary completion date
Jul 1, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
200 participants
Anticipated
Arms
Enhanced Recovery
pre-Enhanced Recovery
Interventions
Enhanced Recovery protocol
Primary outcome measure
Central contacts
Locations
University of Arkansas for Medical Sciences
Recruiting
Little Rock, Arkansas, United States, 72202
Contacts
Sponsor
University of Arkansas
Last update posted
Aug 5, 2026
Last verified
Aug, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Arkansas on 2026-08-05.